BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19059503)

  • 1. Compound-heterozygous Marfan syndrome.
    Van Dijk FS; Hamel BC; Hilhorst-Hofstee Y; Mulder BJ; Timmermans J; Pals G; Cobben JM
    Eur J Med Genet; 2009; 52(1):1-5. PubMed ID: 19059503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FBN1 (R2726W) mutation is not fully penetrant.
    Buoni S; Zannolli R; Macucci F; Ansaldi S; Grasso M; Arbustini E; Fois A
    Ann Hum Genet; 2004 Nov; 68(Pt 6):633-8. PubMed ID: 15598221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal manifestations of Marfan syndrome associated to heterozygous R2726W FBN1 variant: sibling case report and literature review.
    Reyes-Hernández OD; Palacios-Reyes C; Chávez-Ocaña S; Cortés-Malagón EM; Alonso-Themann PG; Ramos-Cano V; Ramírez-Bello J; Sierra-Martínez M
    BMC Musculoskelet Disord; 2016 Feb; 17():79. PubMed ID: 26875674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
    Milewicz DM; Grossfield J; Cao SN; Kielty C; Covitz W; Jewett T
    J Clin Invest; 1995 May; 95(5):2373-8. PubMed ID: 7738200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity for a FBN1 missense mutation: clinical and molecular evidence for recessive Marfan syndrome.
    de Vries BB; Pals G; Odink R; Hamel BC
    Eur J Hum Genet; 2007 Sep; 15(9):930-5. PubMed ID: 17568394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome.
    Arnaud P; Hanna N; Aubart M; Leheup B; Dupuis-Girod S; Naudion S; Lacombe D; Milleron O; Odent S; Faivre L; Bal L; Edouard T; Collod-Beroud G; Langeois M; Spentchian M; Gouya L; Jondeau G; Boileau C
    J Med Genet; 2017 Feb; 54(2):100-103. PubMed ID: 27582083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fibrillin 1 mutation in a case of neonatal Marfan syndrome: the increasing importance of early recognition.
    Sutherell J; Zarate Y; Tinkle BT; Markham LW; Cripe LH; Hyland JC; Witte D; Hopkin RJ; Hinton RB
    Congenit Heart Dis; 2007; 2(5):342-6. PubMed ID: 18377451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome.
    De Backer J; Loeys B; Leroy B; Coucke P; Dietz H; De Paepe A
    Clin Genet; 2007 Sep; 72(3):188-98. PubMed ID: 17718856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype.
    Karttunen L; Raghunath M; Lönnqvist L; Peltonen L
    Am J Hum Genet; 1994 Dec; 55(6):1083-91. PubMed ID: 7977366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.
    Cecchi A; Ogawa N; Martinez HR; Carlson A; Fan Y; Penny DJ; Guo DC; Eisenberg S; Safi H; Estrera A; Lewis RA; Meyers D; Milewicz DM
    Am J Med Genet A; 2013 Sep; 161A(9):2305-10. PubMed ID: 23897642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial neonatal Marfan syndrome due to parental mosaicism of a missense mutation in the FBN1 gene.
    Tekin M; Cengiz FB; Ayberkin E; Kendirli T; Fitoz S; Tutar E; Ciftçi E; Conba A
    Am J Med Genet A; 2007 Apr; 143A(8):875-80. PubMed ID: 17366579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygosity for a FBN1 missense mutation causes a severe Marfan syndrome phenotype.
    Hogue J; Lee C; Jelin A; Strecker MN; Cox VA; Slavotinek AM
    Clin Genet; 2013 Oct; 84(4):392-3. PubMed ID: 23278365
    [No Abstract]   [Full Text] [Related]  

  • 13. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40.
    Tiecke F; Katzke S; Booms P; Robinson PN; Neumann L; Godfrey M; Mathews KR; Scheuner M; Hinkel GK; Brenner RE; Hövels-Gürich HH; Hagemeier C; Fuchs J; Skovby F; Rosenberg T
    Eur J Hum Genet; 2001 Jan; 9(1):13-21. PubMed ID: 11175294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new novel mutation in FBN1 causes autosomal dominant Marfan syndrome in a Chinese family.
    Dong J; Bu J; Du W; Li Y; Jia Y; Li J; Meng X; Yuan M; Peng X; Zhou A; Wang L
    Mol Vis; 2012; 18():81-6. PubMed ID: 22262941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel FBN1 gene mutation in a large Pakistani family with Marfan syndrome.
    Micheal S; Khan MI; Akhtar F; Weiss MM; Islam F; Ali M; Qamar R; Maugeri A; den Hollander AI
    Mol Vis; 2012; 18():1918-26. PubMed ID: 22876116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential allelic expression of a fibrillin gene (FBN1) in patients with Marfan syndrome.
    Hewett D; Lynch J; Child A; Firth H; Sykes B
    Am J Hum Genet; 1994 Sep; 55(3):447-52. PubMed ID: 7915876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel non-synonymous mutation in the transforming growth factor beta binding protein-like (TB) domain of the fibrillin-1 (FBN1) gene in a Han Chinese family with Marfan syndrome (MFS).
    Qin Y; Yan J; Simpson JL; Gu HF; Wang LC; Chen ZJ
    Neuro Endocrinol Lett; 2007 Oct; 28(5):629-32. PubMed ID: 17984934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.
    Robinson PN; Booms P; Katzke S; Ladewig M; Neumann L; Palz M; Pregla R; Tiecke F; Rosenberg T
    Hum Mutat; 2002 Sep; 20(3):153-61. PubMed ID: 12203987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variability in Marfan syndrome in a family with a novel nonsense FBN1 gene mutation.
    Díaz de Bustamante A; Ruiz-Casares E; Darnaude MT; Perucho T; Martínez-Quesada G
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):380-1. PubMed ID: 21840105
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation.
    Collod-Béroud G; Lackmy-Port-Lys M; Jondeau G; Mathieu M; Maingourd Y; Coulon M; Guillotel M; Junien C; Boileau C
    Am J Hum Genet; 1999 Sep; 65(3):917-21. PubMed ID: 10441597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.